Resting Heart Rate
A slow pulse at rest goes with living longer, and it costs nothing to measure. But it is a readout, not a dial: the trials that slowed the heart on purpose mostly failed, so it is a number worth watching and a poor thing to chase.
Track your resting heart rate the same way each time — ideally overnight with a wearable — and compare it only with your own average over the past few weeks. A rise that lasts for weeks is a prompt to look for a cause (illness, poor sleep, drinking, a thyroid problem, lost fitness), not a number to push down. The thing that lowers it durably is regular aerobic training, over months.
What the number predicts
This is one of the most consistently replicated findings in heart research, across studies covering well over a million people: every step up the ordinary range carries a little more risk. The largest pooling of studies — 87 of them — found death from any cause about 17% higher for each extra 10 beats per minute[1]. An earlier analysis of 46 studies and about 1.2 million people put it lower, at 9% per 10 beats, and found signs that small studies with null results had gone unpublished[2]. The studies disagree with each other enormously, so treat these as a direction and a rough size, not a precise figure.
The risk sits mostly at the top of the range. In that earlier analysis, people above 80 beats per minute had about 45% higher mortality than those in the lowest group; between 60 and 80 the excess was much smaller, about 12%.
It predicts deaths that have nothing to do with the heart. In an Australian study of about 41,000 adults, each extra 10 beats went with 11% higher heart-disease mortality, 10% higher cancer mortality and 20% higher mortality from all other causes[3]. Breast, bowel, kidney and lung cancer deaths were each raised. A 2026 study of 615,730 cancer-free Taiwanese adults found almost the same cancer figure, though it came from the same screening programme as the blood-pressure comparison below[4]. A marker that predicts kidney cancer about as well as heart disease is not describing a heart mechanism. Part of what it picks up is almost certainly illness that has not been diagnosed yet — inflammation or a cancer can raise the rate long before it declares itself. That reverse arrow is a caveat on every number in this section.
A change matters more than a level. In the same Australian cohort, people whose resting rate rose by more than 15 beats over about a decade had higher mortality than those whose rate held steady.
It shows up young. Pooling a Taiwanese and a Norwegian cohort — about 692,000 adults followed for some 25 years — people with normal blood pressure but a raised heart rate (80–99) died at a higher rate than people with high blood pressure but a normal heart rate. Under 40, high blood pressure did not significantly predict death at all; a raised heart rate did at every age[5]. An independent US analysis of adults aged 20–49 found each 10 beats went with about 17–26% higher long-term mortality, visible by the early-to-mid 30s[6]. All of this is observational: it shows how much predictive weight the number carries, not that lowering it would buy anything back.
It is not just a measure of fitness
Fit people have slow hearts, so the obvious worry is that resting heart rate is fitness in disguise. Several cohorts that measured fitness with an exercise test say it probably is not.
In a Dallas clinic cohort of about 50,000 adults given a maximal treadmill test, a resting rate of 80 or more still carried about 35% higher cancer mortality than one below 60 after adjusting for fitness[7], and unfit people with a low rate died at about the same rate as fit people with a high one[8]. In about a million Swedish men examined at conscription, a high rate at 18 still predicted slightly higher death decades later, about 9%, though not cardiovascular death[9]. In about 2,800 Danish middle-aged men followed for 16 years, mortality still rose 16% per 10 beats after adjusting for a bike-test fitness measure[10].
One small Belgian study of 439 men hints that the rate your heart runs at through the day matters more than one clinic reading: split into thirds, a 24-hour average looked like the stronger predictor. But it recorded only 48 deaths, and measured as a continuous number the two readings performed almost the same[11]. Suggestive, not settled.
Fitness and rate are still linked. In Norway, a resting rate above 80 predicted lower fitness in men 23 years later — but being physically active largely cancelled that disadvantage[12].
Slowing the heart on purpose mostly doesn't help
This is the question that decides whether the number is worth acting on, and it has a real answer. Ivabradine, a drug that slows the heart's own pacemaker without changing blood pressure or how hard the heart squeezes, is close to a clean experiment on the number itself. Three large randomised trials have tested it.
- In heart failure, it works. In about 6,600 people with a weak heart (pumping out 35% or less of the blood in the main chamber with each beat, against a healthy 55–70%) and a rate of at least 70, cardiovascular death or a heart-failure admission fell from 29% to 24% over about two years[13].
- In coronary disease without heart failure, it did nothing. In about 19,000 people the drug held the average rate about 10 beats below placebo, yet heart deaths or heart attacks occurred in 6.8% on the drug and 6.4% on placebo. One subgroup, people whose angina limited their activity, had more events on the drug — a signal, not proof of harm. And 18% developed a heart rate slow enough to be flagged, against about 2% on placebo[14].
- In coronary disease with a weakened heart, it also did nothing. In about 11,000 people, lowering the rate by 6 beats left the main outcome exactly unchanged[15].
Other evidence points the same way. In nine trials of beta-blockers for high blood pressure, the trials that reached the lowest heart rates had the worst outcomes — a comparison across trials, so it cannot show the slowing caused harm, but the opposite of what a lever would do[16]. After a heart attack with normal pumping, pooling five recent trials of about 17,800 people found a beta-blocker made no meaningful difference to death, another heart attack or heart failure (8.1% against 8.3%)[17]. Where the pump was mildly weakened, beta-blockers did cut those events by about a quarter[18], and one Scandinavian trial that enrolled both groups found a modest benefit, mostly fewer repeat heart attacks[19]. Beta-blockers do more than slow the heart and these trials were not blinded, so they are not a clean test of the number — but where the pump is normal, they agree with the ivabradine trials.
Genetics is the nearest thing to a test in healthy people. Some people inherit gene variants that set their heart slightly faster for life. A study that found these variants in up to about 835,000 people saw no sign that they lead to dying sooner, though they were linked to more of one form of heart-muscle disease and less atrial fibrillation and stroke[20]. A null genetic result is not proof, but it is what you would expect if the rate is mostly a readout.
No trial has ever lowered resting heart rate in healthy adults. The pattern is coherent: in heart failure a fast heart is part of the disease, and slowing it gives the failing ventricle time to fill. Elsewhere, a fast heart looks like a readout of something else — deconditioning, an overactive stress response, inflammation, illness. Lower the readout without changing the cause and nothing improves.
Why the textbook range tells you almost nothing
The familiar 60–100 band describes a population, not you. In a study of about 92,000 US adults wearing wrist trackers — some 33 million daily readings — the average was 65, but personal averages ran from about 40 to 109[21]. The same study found:
- Personal averages differed by age, sex, body weight and habitual sleep.
- A seasonal cycle: lowest in July, highest in January.
- Within one person the value was fairly stable, but one in five had at least one week where it shifted by 10 beats or more.
So two people can both be normal and 40 beats apart, and one person can drift 10 beats in a week with nothing wrong. Only your own rolling average, built over weeks, makes a reading meaningful.
Keep the method the same, too. In about 10,900 UK adults the average was 67 sitting, 64 lying down and 57 asleep[22], so an overnight wearable figure should not be compared with a seated clinic reading. For the rate itself, consumer wearables are on average within about 3% of reference equipment[23], and overnight they track it far better than they track heart rate variability, though agreement differs between brands[24]. Rate is the easier and better-studied of the two; heart rate variability covers the other measure and how devices compare.
A single reading can be thrown off by a recent meal, caffeine, last night's alcohol, standing, time of day, an infection you are incubating, dehydration, a poor night's sleep, anxiety in a clinic room or a thyroid problem — see Thyroid. None of these has a well-measured size, which is the point: stop reading single numbers.
What moves it
Training — the one durable lever, and slow. Across 191 studies, every form of exercise lowered resting heart rate, with endurance training and yoga reliably doing so in both sexes[25]. Interval training lowered it by about 4 beats against not exercising[26]. The fall is larger the higher you start and smaller the older you are. In sedentary adults over 60, the effect was about 6 beats, and programmes shorter than about 30 weeks generally didn't produce a significant fall[27]. Plan in months. See Zone 2.
Alcohol — the most visible thing in your own data. In a lab study of 26 healthy adults, drinking before bed raised heart rate through the night by about 4% after one to two drinks and 14% after three to four (the lower number for women); after the higher dose the rise lasted all night[28]. See Alcohol.
Omega-3 — a small effect. Across 51 trials, supplements lowered heart rate by about 2 beats. In trials that gave one fatty acid alone, DHA lowered it while EPA showed no clear effect — a comparison across different trials, in a review partly written by staff of an omega-3 manufacturer[29]. See Omega-3.
Drugs that push it up. GLP-1 weight-loss drugs such as semaglutide and tirzepatide raise resting heart rate by about 3 to 4 beats on average in people without diabetes, and more at the highest doses of some newer drugs[30]; in people with type 2 diabetes, tirzepatide's rise grows with the dose[31]. In pigs, the hormone these drugs mimic sped up the heart's pacemaker directly[32]. On these drugs a rise is expected and is not lost fitness; compare against your on-drug baseline.
Drugs that pull it down. On a beta-blocker or another rate-slowing drug, resting heart rate stops reflecting your nervous system and starts reflecting the dose.
Vaping — a brief rise. Heart rate was about 1.4 beats higher within an hour after a vaping session, with small rises in blood pressure and briefly stiffer arteries; the studies vary widely, smaller positive ones may be over-represented, and none of this shows what regular vaping does to your resting rate[33]. See Smoking and nicotine.
Sauna — nothing. Across eleven randomised trials, two to fifteen weeks of regular heat left resting heart rate unchanged[34]. See Sauna.
Bedtime — real but tiny. Across about 256,000 nights in 557 students, going to bed 30 minutes later than usual went with an overnight rate higher by under 0.2 beats; going to bed an hour or more earlier than usual was also linked with a higher rate[35]. Most single-night influences are this small — don't over-read a bad morning.
When a slow pulse is a problem
For most people a slow pulse is good news, and endurance athletes often sit in the 40s — a normal effect of training known as athletic bradycardia. In a trained athlete with no symptoms, a rate above 30 is treated as a normal training effect. At or below 30, or with pauses of 3 seconds or longer, doctors should check how the heart rate responds to exercise[36]. Such readings are uncommon but not rare: on 24-hour monitoring of 465 mostly young elite endurance athletes, 1 in 50 dipped to 30 or below. Over five and a half years this was not linked to health problems, though the most extreme group was very small[37].
The number matters less than how the heart responds. A trained heart speeds up normally on demand and causes no symptoms. A failing pacemaker does not, and the giveaways are dizziness, fainting, breathlessness or exhaustion on exertion out of proportion to your fitness. Those symptoms with a slow pulse warrant evaluation however much you train.
Heavy endurance training may leave a lasting mark. Among about 209,000 Swedish long-distance skiers, men had about 17% more pacemaker implants than non-skiers, with the highest rates in those with the most races and fastest times; women showed no excess, and skiers with a pacemaker did not die at a higher rate[38]. That is an association, not proof that training caused it, and why athletes' hearts slow — a stronger calming signal from the vagus nerve, or a physically remodelled pacemaker — is still unsettled.
What to actually do
- Prefer overnight or continuous measurement to a spot check — an average over many hours is less exposed to the noise of one moment.
- If you take it by hand, do it the same way each time: seated, rested for several minutes, before caffeine, at a consistent time of day, counting for a full 60 seconds.
- Compare against your own average, not a chart, and watch the trend, not the day. A rise held over weeks is the signal.
- Treat a rise as a prompt to find the cause: new medication, poor sleep, more drinking, a thyroid problem, a developing illness, lost fitness. The number is the smoke.
- Don't take a drug to lower it if you are otherwise well. The trials above give no reason to expect it to help.
What's overrated
- Chasing a lower number. Pushing it down directly with ivabradine failed everywhere except heart failure.
- Reading it as a fitness score. It is not simply fitness — and an active person with a fast heart largely closes the gap anyway.
- Precision about the effect size. "17% per 10 beats" is quoted everywhere; the studies behind it disagree too much for a precise figure.
Further reading
- Aune D, et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis 2017.[39]
- Zhang D, et al. Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ 2016.[40]
- Seviiri M, et al. Resting heart rate, temporal changes in resting heart rate, and overall and cause-specific mortality. Heart 2018.[41]
- Wen CP, et al. Resting heart rate — the forgotten risk factor? Comparison of resting heart rate and hypertension as predictors of all-cause mortality in 692,217 adults in Asia and Europe. Prog Cardiovasc Dis 2025.[42]
- Jensen MT, et al. Elevated resting heart rate, physical fitness and all-cause mortality: a 16-year follow-up in the Copenhagen Male Study. Heart 2013.[43]
- Fox K, et al. Ivabradine in stable coronary artery disease without clinical heart failure (SIGNIFY). N Engl J Med 2014.[44]
- Swedberg K, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010.[45]
- Bangalore S, et al. Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol 2008.[46]
- Quer G, et al. Inter- and intraindividual variability in daily resting heart rate and its associations with age, sex, sleep, BMI, and time of year: retrospective, longitudinal cohort study of 92,457 adults. PLoS One 2020.[47]
- Reimers AK, et al. Effects of exercise on the resting heart rate: a systematic review and meta-analysis of interventional studies. J Clin Med 2018.[48]
- Drezner JA, et al. International criteria for electrocardiographic interpretation in athletes: consensus statement. Br J Sports Med 2017.[49]